Purchase Order 75N93023P00918
Award Date
7/11/23
Potential Completion Date
1/31/24
Potential Value
$29K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,459 purchase order to Genscript USA Inc. to provide custom subcloning and antibody sequencing services in support of the agency's biomedical research efforts. Work will be performed by Genscript in Piscataway, New Jersey over a three-month period concluding in early October 2023. The firm fixed price contract was awarded under an unidentified agency-wide...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,779.98 firm fixed price purchase order to Genscript USA Inc. for transient expression, purification and plasmid preparation services in support of AMBIS program activities. Performance will take place in Piscataway, New Jersey over a two month period concluding on September 30, 2023. The contract calls for Genscript to deliver requested biomanufacturing...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $250,000 firm fixed price purchase order to Genscript USA Inc. of Piscataway, New Jersey. The order is for gene production and protein expression services to support the agency's research efforts. Services include gene synthesis, cloning, plasmid preparation, and protein expression and purification. The sole source award was negotiated under the authority of 41 U.S.C. 1901(a)(1) based on...
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a firm fixed-price purchase order contract worth $66,835.54 to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for the custom synthesis of genes and antibodies to support NIAID's biomedical research and public health initiatives. The contract was awarded on a sole-source basis under the authority of FAR 13.106-1 due to Genscript being the...
This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $20,827.75 purchase order to Genscript USA Inc. to provide customized protein production using a baculovirus expression system. Performance will take place in Piscataway, New Jersey over a period of approximately three months concluding in mid-December 2023. The firm fixed price contract calls for Genscript to deliver the requested proteins without further...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $12,110.90 firm fixed-price purchase order was for the supply of unspecified chemicals and is designated as a total small business set-aside. Genscript USA Inc. is a well-established provider of molecular biology products and services to federal...
This $12,922.70 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH), to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The award is for the provision of various laboratory equipment and accessories, including thermostats, centrifuges, and rotors. While the contract has no set-aside...
<p>Genscript USA Inc. has been awarded a $11,395.74 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide purified peptide services. The one-year contract, which runs from July 2023 through July 2024, will support NIH/NIAID's research efforts. No subcontractors or set aside designations were identified. Genscript will perform the peptide purification work at its facility in Piscataway, New Jersey.</p>
The federal contract HHSN272201600094P was awarded to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,035.50 Firm Fixed Price contract was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract does not have a set-aside designation. Under this contract, Genscript is providing a wide range of molecular...